Northfield Labs Earnings Conference Call (Q3 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Apr 10 Calls Today's Calls

Call Details Northfield Labs Earnings Conference Call (Q3 2008) Thu, Apr 10, 2008, 11:00 am Eastern Listen to the archived event audio About Northfield Labs (NasdaqGM:NFLD) Northfield Laboratories, Inc., a development stage company, engages in the development, testing, manufacture, marketing, and distribution of hemoglobin-based blood substitute products. It primarily develops PolyHeme, a Phase III clinical trial human hemoglobin-based oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss when an oxygen-carrying fluid is required and red blood cells are not available. The company was founded in 1985 and is headquartered in Evanston, Illinois. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials